Najib El-Sayed, associate professor in the University of Maryland's College of Chemical and Life Sciences, led the transatlantic research team, along with Matthew Berriman of the UK's Wellcome Trust Sanger Institute. Their work is published in the July 16, 2009 edition of Nature and featured on the journal's cover.
Schistosomiasis is one of several neglected tropical diseases prevalent across much of Africa, Asia, and South America and affects mainly poor populations living in areas where water is unsafe, sanitation inadequate, and basic health care unavailable. It impacts adults and children's capacity to work and learn, and often leads to death. Knowing this parasite's genome sequence, scientists will now be able to develop much-needed new treatments for schistosomiasis, for which a vaccine does not yet exist. The drug commonly used to treat this parasitic infection does not prevent re-infection, and there are growing reports of drug resistance and treatment failures.
"We have used state of the art genetic and computational approaches to decipher the genome of this pathogen and to facilitate drug discovery," said El-Sayed, senior author of the paper. "Many promising leads for drug development targets have emerged."
The paper reports the analysis of approximately 12,000 genes encoded in the nuclear DNA of Schistosoma mansoni, the flatworm that causes schistosomiasis. This comprehensive genome sequence enabled researchers to map out metabolic networks that are essential to survival of the parasite, thereby revealing potential areas of vulnerability. Through bioinformatics and chemogenomic screens, the study also explores cost effective ways to develop new therapies, such as the possibility that existing pharmaceutical drugs might be used to target schistosomiasis.
"We deliberately looked for similarities between us and the parasite so that we may be able to exploit the activities of existing drugs, marketed for different purposes" said Berriman (joint senior author) of the study.
The researchers compared S. mansoni genes with known 'druggable' protein targets of the human host and human-infective pathogens in use by pharmaceuticals on the market; matches indicate potential for existing drugs to be repurposed as anti-schistosomal drugs.
"The accomplishment of sequencing the S. mansoni genome is the critical first step in developing the drugs and vaccines we urgently need to effectively combat schistosomiasis," said Peter Hotez, Distinguished Research Professor and Chair of the Department of Microbiology, Immunology, and Tropical Medicine at George Washington University and President of the Sabin Vaccine Institute. "It is one of the most important neglected tropical diseases, with evidence suggesting that it may be as important as better known conditions such as malaria or HIV, because of the number of people it affects with chronic, debilitating infections."
For a sidebar with S. mansoni image: The S. mansoni parasite has a complex life cycle, perpetuated by poor water conditions. The parasite's eggs hatch in water, enter into snail hosts, then travel to human hosts through contaminated water sources, such as bathing and swimming areas. The mature fluke worm grows in the human blood vessel system, depositing eggs around the bladder or intestines, which triggers the formation of excess connective tissue in those regions. The parasite's eggs are passed to the liver or exit through the urine or feces, continuing the cycle of infection.
This work was supported primarily by grants from the National Institutes of Health (NIAID) and the Wellcome Trust. For further information, please contact Najib El-Sayed by e-mail at firstname.lastname@example.org or by telephone at +1 (301) 405-2999.
Najib El-Sayed is an Associate Professor of Cell Biology and Molecular Genetics with a joint appointment in the Center for Bioinformatics and Computational Biology at the University of Maryland Institute for Advanced Computer Studies (UMIACS). He is also affiliated with the Maryland Pathogen Research Institute (MPRI). The El-Sayed research group is currently focused on decoding and comparing the genomes of a variety of human pathogens (with the goal of better understanding mechanisms of virulence) and unveiling interactions between pathogen and host proteins. Another ongoing project uses metagenomic approaches to investigate the gut microbial population in children with autism spectrum disease.
July 16 Issue of Nature: http://www.nature.com/nature/index.html
Kelly Blake | EurekAlert!
Novel mechanisms of action discovered for the skin cancer medication Imiquimod
21.10.2016 | Technische Universität München
Second research flight into zero gravity
21.10.2016 | Universität Zürich
Researchers from the Institute for Quantum Computing (IQC) at the University of Waterloo led the development of a new extensible wiring technique capable of controlling superconducting quantum bits, representing a significant step towards to the realization of a scalable quantum computer.
"The quantum socket is a wiring method that uses three-dimensional wires based on spring-loaded pins to address individual qubits," said Jeremy Béjanin, a PhD...
In a paper in Scientific Reports, a research team at Worcester Polytechnic Institute describes a novel light-activated phenomenon that could become the basis for applications as diverse as microscopic robotic grippers and more efficient solar cells.
A research team at Worcester Polytechnic Institute (WPI) has developed a revolutionary, light-activated semiconductor nanocomposite material that can be used...
By forcefully embedding two silicon atoms in a diamond matrix, Sandia researchers have demonstrated for the first time on a single chip all the components needed to create a quantum bridge to link quantum computers together.
"People have already built small quantum computers," says Sandia researcher Ryan Camacho. "Maybe the first useful one won't be a single giant quantum computer...
COMPAMED has become the leading international marketplace for suppliers of medical manufacturing. The trade fair, which takes place every November and is co-located to MEDICA in Dusseldorf, has been steadily growing over the past years and shows that medical technology remains a rapidly growing market.
In 2016, the joint pavilion by the IVAM Microtechnology Network, the Product Market “High-tech for Medical Devices”, will be located in Hall 8a again and will...
'Ferroelectric' materials can switch between different states of electrical polarization in response to an external electric field. This flexibility means they show promise for many applications, for example in electronic devices and computer memory. Current ferroelectric materials are highly valued for their thermal and chemical stability and rapid electro-mechanical responses, but creating a material that is scalable down to the tiny sizes needed for technologies like silicon-based semiconductors (Si-based CMOS) has proven challenging.
Now, Hiroshi Funakubo and co-workers at the Tokyo Institute of Technology, in collaboration with researchers across Japan, have conducted experiments to...
14.10.2016 | Event News
14.10.2016 | Event News
12.10.2016 | Event News
21.10.2016 | Health and Medicine
21.10.2016 | Information Technology
21.10.2016 | Materials Sciences